Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05767021
What this trial is testing

Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative ColitisUlcerative Colitis Chronic
Eli Lilly and Company 172
Large-scale testing (Phase 3)Active Not RecruitingNCT04624230
What this trial is testing

Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 118
Testing effectiveness (Phase 2)Ended earlyNCT02209792
What this trial is testing

Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Boehringer Ingelheim 284
Large-scale testing (Phase 3)Ended earlyNCT03259334
What this trial is testing

Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Shire 380
Testing effectiveness (Phase 2)Looking for participantsNCT06721962
What this trial is testing

Treatment of Moderate to Severe Refractory Crohn's Disease

Who this might be right for
Crohns Disease
Tr1X, Inc. 39
Testing effectiveness (Phase 2)Ended earlyNCT05688852
What this trial is testing

VTX958 for the Treatment of Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Ventyx Biosciences, Inc 107
Large-scale testing (Phase 3)Study completedNCT00356408
What this trial is testing

Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Pharma 106
Very early researchNot Yet RecruitingNCT07353450
What this trial is testing

Cizutamig for Patients With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Ruijin Hospital 15
Large-scale testing (Phase 3)Ended earlyNCT00984568
What this trial is testing

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 28
Testing effectiveness (Phase 2)Study completedNCT01294410
What this trial is testing

Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 305
Post-approval studies (Phase 4)Study completedNCT01408810
What this trial is testing

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Grupo de Estudo da Doença Inflamatória Intestinal 21
Large-scale testing (Phase 3)Study completedNCT03915769
What this trial is testing

To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Celgene 198
Testing effectiveness (Phase 2)Study completedNCT03760003
What this trial is testing

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 355
Large-scale testing (Phase 3)Study completedNCT02914561
What this trial is testing

Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Lakefront Biotherapeutics NV 1,372
Not applicableEnrolling By InvitationNCT07721441
What this trial is testing

Predictive Efficacy of Fecal Calprotectin Assay by Magnetic Particle Chemiluminescence for Mucosal Healing in Moderate-to-Severe Ulcerative Colitis Patients Undergoing Initial Biologic Therapy（PRECAL）

Who this might be right for
Ulcerative Colitis (UC)
Tang-Du Hospital 200
Not applicableStudy completedNCT01083680
What this trial is testing

Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine

Who this might be right for
Crohn's Disease
AbbVie (prior sponsor, Abbott) 4,107
Testing effectiveness (Phase 2)Study completedNCT01647516
What this trial is testing

Efficacy and Safety Study of Ozanimod in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Celgene 199
Testing effectiveness (Phase 2)Study completedNCT01714726
What this trial is testing

Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn's Disease
AstraZeneca 121
Testing effectiveness (Phase 2)Ended earlyNCT02895100
What this trial is testing

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Protagonist Therapeutics, Inc. 98
Large-scale testing (Phase 3)Active Not RecruitingNCT06063967
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.

Who this might be right for
Crohn's Disease
AbbVie 289
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation